Enrollment change • Trial completion date • Trial primary completion date • Combination therapy • Metastases
|
NRAS (Neuroblastoma RAS viral oncogene homolog)
|
NRAS mutation • NRAS Q61 • NRAS G12 • NRAS G13
|
Tecentriq (atezolizumab) • Cotellic (cobimetinib) • ifebemtinib (IN10018)